Bopegamage S, Petrovicova A, Stara M
Folia Microbiol (Praha). 2001; 45(1):61-3.
PMID: 11200674
DOI: 10.1007/BF02817452.
Nugent C, Kirkegaard K
J Virol. 1995; 69(1):13-22.
PMID: 7983702
PMC: 188543.
DOI: 10.1128/JVI.69.1.13-22.1995.
Basavappa R, Syed R, Flore O, Icenogle J, Filman D, Hogle J
Protein Sci. 1994; 3(10):1651-69.
PMID: 7849583
PMC: 2142606.
DOI: 10.1002/pro.5560031005.
Carter M, Ter Meulen V
Adv Virus Res. 1984; 29:95-130.
PMID: 6397053
PMC: 7131468.
DOI: 10.1016/s0065-3527(08)60406-6.
van der Werf S, Wychowski C, Bruneau P, Blondel B, Crainic R, HORODNICEANU F
Proc Natl Acad Sci U S A. 1983; 80(16):5080-4.
PMID: 6308670
PMC: 384192.
DOI: 10.1073/pnas.80.16.5080.
Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.
Chow M, Baltimore D
Proc Natl Acad Sci U S A. 1982; 79(23):7518-21.
PMID: 6296837
PMC: 347371.
DOI: 10.1073/pnas.79.23.7518.
Monoclonal antibodies against microorganisms.
Polin R
Eur J Clin Microbiol. 1984; 3(5):387-98.
PMID: 6209135
DOI: 10.1007/BF02017358.
Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.
Hughes J, Stanton L, Tomassini J, Long W, Scolnick E
J Virol. 1984; 52(2):465-73.
PMID: 6208377
PMC: 254547.
DOI: 10.1128/JVI.52.2.465-473.1984.
Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.
Baxt B, MORGAN D, Robertson B, Timpone C
J Virol. 1984; 51(2):298-305.
PMID: 6205165
PMC: 254438.
DOI: 10.1128/JVI.51.2.298-305.1984.
A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.
Wychowski C, van der Werf S, Siffert O, Crainic R, Bruneau P, Girard M
EMBO J. 1983; 2(11):2019-24.
PMID: 6196195
PMC: 555403.
DOI: 10.1002/j.1460-2075.1983.tb01694.x.
Epitope evolution in poliovirus maturation.
Rombaut B, Vrijsen R, Boeye A
Arch Virol. 1983; 76(4):289-98.
PMID: 6194772
DOI: 10.1007/BF01311196.
Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.
Emini E, Kao S, Lewis A, Crainic R, Wimmer E
J Virol. 1983; 46(2):466-74.
PMID: 6188863
PMC: 255148.
DOI: 10.1128/JVI.46.2.466-474.1983.
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
Emini E, Jameson B, Lewis A, Larsen G, Wimmer E
J Virol. 1982; 43(3):997-1005.
PMID: 6183443
PMC: 256210.
DOI: 10.1128/JVI.43.3.997-1005.1982.
The use of monoclonal antibodies in virology.
Oxford J
J Hyg (Lond). 1982; 88(3):361-8.
PMID: 6177742
PMC: 2134102.
DOI: 10.1017/s0022172400070236.
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from poliovirus-infected cells.
Corrias M, Flore O, Broi E, Marongiu M, Pani A, Torelli S
J Virol. 1987; 61(2):561-9.
PMID: 3027383
PMC: 253981.
DOI: 10.1128/JVI.61.2.561-569.1987.
Modulation of humoral response to a 12-amino-acid site on the poliovirus virion.
Icenogle J, Minor P, Ferguson M, Hogle J
J Virol. 1986; 60(1):297-301.
PMID: 3018295
PMC: 253930.
DOI: 10.1128/JVI.60.1.297-301.1986.
Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles.
Fricks C, Icenogle J, Hogle J
J Virol. 1985; 54(3):856-9.
PMID: 2987536
PMC: 254874.
DOI: 10.1128/JVI.54.3.856-859.1985.
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.
Chow M, Yabrov R, BITTLE J, HOGLE J, Baltimore D
Proc Natl Acad Sci U S A. 1985; 82(3):910-4.
PMID: 2983321
PMC: 397157.
DOI: 10.1073/pnas.82.3.910.
A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
Thomas A, Brioen P, Boeye A
J Virol. 1985; 54(1):7-13.
PMID: 2983121
PMC: 254753.
DOI: 10.1128/JVI.54.1.7-13.1985.
Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
Uhlig H, Haardt F, Dernick R
Arch Virol. 1985; 83(3-4):295-303.
PMID: 2578787
DOI: 10.1007/BF01309924.
